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HighRataaofApoptosisin HumanCoronary
AtharoaclaroticLasionaLackingCompensatory
Enlargement
A. Heeean, M. Ignateacu, R. Ullrich, V. Rae, LM. Lang, D.H. Glogar.
University of Vienna, Austria
Compensatory enlargement of atherosclerotic arteries is an adaptive pro-
0sss that is thought to determine vascular lumen size. Apoptoeis of cells of
the vascular wall may modulate the cellularity of lesions that produce vas-
cular obstruction. To investigate the association of apoptosis with adaptive
changes in vessel size triggered by atherosclerosis, intravascular ultrasound
was performed in 23 severe primary corona~ stenoees prior to directional
mronary atherectomy. Compensatory enlargement (CE+) was defined as an
increase in vessel cross-sectional area at the lesion site of at least 10Yocom-
pared to the proximal reference site. Lesions failing to show compensatory
vessel enlargement were classified as (CE–). Atheractomy specimens were
analyzed utilizing in situ labeling of DNA strand breaks (TUNEL). Cells were
cleeeifiad se TUNEL-pesitive (TUNEL+) when both positive immunoreactiv-
ily and key morphologic features of apoptosis (e.g., pycnosis) were present.
Apoptotic indices were obtained dividing the number of TUNEL+ cells by the
total number of counted ceils per field (Total).
Results:
Group TUNEL+ (+ SD) Total (+ SD) Index (+ SD)
CE+ (n = 9) 7.8 & 5.2 240.7 + 69.1 3.0 * 1.9
CE– (n= 14) 21.4 & 17.4 233.5 * 121,4 It.z * 9.1
p-vslue 0.035 0,87 0.015
In conclusion, an increased number of TUNEL+ cells was asaociatad
with Ieaions lacking compensatory vessel enlargement. Identification of sig-
nals and mechanisms underlying increased apoptosis in (CE–) lesions will
contribute to a better understanding of arterial remodeling.
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m7341 TheBan6fitsof BriafAntacsdantIachamiaonPlatelet-MadiatedThrombosisaraMimickedbyBriaf
IntracoronaryAdanosineInfuaion
K. Hata, R.A. Kloner, K. Przyklenk. Good Samaritan Hospital& USC, Los
AngedasCA, USA
Patients with angina prior to myocerdial infarction exhibit enhanced recov-
ery of coronary perfusion following thrombolysis by an as-yet unknown
mechanism. Wa propose that adenosine released during brief antecedent
ischemisJraperfusion may attenuate platelet aggregation and thereby con-
tribute to improved vessel patency. To test this theofy, 25 dogs underwent
arterial injury + cdronav stenosis, resulting in repeated cyclic variations in
coronary flow (CFV’S)caused by the spontaneous forrnationldislodgement of
platelet thrombi. Immediately before injury+ stenosis, 10 dogs received 10
min of antecedent, mechanically-induced coronary occlusion (CO) followed
by 10 min of reflow, 5 received a 10 min intracoronary infusion of adeno-
sine (400 pglmin) and 10 min of washout, while 10 served as time-matched
controla. Coronary blood flow was monitored at baseline, during the 20 min
intervention period, and for 1 h post-stenosis. Vessel patency was compared
by quantifying the number of CFV’s, the duration of total thrombotic occlusion
(flow =0), and the area of the flow-time profile (expressed as a % of baseline
flow x 80 rein):
#ClW’s Zero flow ‘A Flow-timearea
Control 3*1 26& 6 min 20& 6“I&
BriefCO 7&2 10+ 6 min 45& 7%
Adanoaine 18& 6 10 i 5 min 55* 10%
Bsseline and stenotic blood flows were comparable among the groups
and, se expected, all dogs developed platelet aggregationfdislodgement
following injury + stenosis. Controls exhibited 23 CFVS, the duration of
total thrombotic occlusion waa 28 rein, and the flow-time area was 20% of
baseline. In contrast, both brief antecedent CO and brief adenosine infu-
sion were associated with a greater incidence of CFVS, a reduction in zero
flow duration to 10 rein, and an increase in the flow-time area to 45-55%
(P = 0.01, o.~ and 0.03 vs controls, respectively).Thus, the benefits of
brief ischemitireperfusion on platelet-mediated thrombosis in damaged and
stenotic canine coronary arteries are mimicked by brief infueion of adenosine,
implying that adenosine may contribute to the improved veesel patency seen
with antecedent angina.
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Platelat-ThrombuaFormationIn PatientaWith
CoronaryArtaryDisaaaa
M. Shechter, N.B. Merz, R.K. Rude, M. Paul-Labrador, S. Meisel,
M.D. Molloy, B. Cercek, P.K.Shah, S. Kaul. Cedara-Sirrai A&dica/ Center
and USC Orthopedic Hospital, CA, USA
Although reduced intracellular levels of magnesium ([Mg]i) have been de-
scribed in patients with acute Ml, ikasignificance remains unknown. To deter-
mine whether reduced [Mg]i enhances platelet-dependent thrombosis (PDT),
we measured PDT in 42 stable CAD patients on aspirin and lipid-lowering
therapy by exposing porcine aortic media to their flowing venous blood for
5 min at a shear rate of 800 see-l at 37QC using an ex-vivo chamber
model. PDT was measured by computerized morphometry and expressed
as Km2/Km2 of the aortic surface. The [Mg]i in isolated mononuclear cells
was measured by atomic absorption spectrophotometry (normal range: 1.23
+ 0.02 @mg protein). Patients were divided into two groups: Group A below
and Group B above the median [Mg]i level (1.11 @mg protein).
Results:
[Mg]i (wg/mgprotein) , PDT (&m2/Mm2)
GroupA (n = 21) 0.9s + 0.09 3.10 & 2.70
GroupB (n =21) 1,37 + 0.28* 0.99 + 0.63a
Valuesare mean + SD; *p <0.0001, ‘P <0.03 vs GroupA
There were nosignificent differences in age, eerumtotal cholesterol, LDL-
C, HDL-C, triglycerides, fibrinogen, or serum magnesium levels between
the two groups. Conclusion: Platelet-dependent thrombosis is significantly
increased in stable CAD patients with low [Mg]i. This finding demonstrate
that low intracellular magnesium levels may favor arterial thrombus formation
in CAD patients, suggesting a potential role for magrwsium supplementation
in CAD.
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-l lndu.ib,a~itric~~ide~YnthasaisAsaociatedwith
ThrombiAftarEx~erimentalAnaioolastvandin
AdvancedHuma;CoronaryAt~aroacla;oticPlaquea
K. Cromheeke, J. Bosmans, M. Kockx, H. Bult, C. Vrints, A.G. Herman. The
University of Arrtwerp (yIA), Arrtwerp, Belgium
The purpose of this study was to localise inducible NO synthase (iNOS)
expressing cells after balloon angioplasty of the rabbit carotid artery, and in
human coronary atherosclerotic plaques that are the substrate for therapeu-
tical angioplasty.
The carotid arferyof New Zealand white rabbits was dilated with a2.5 mm
balloon and examined after 1,2 and 3 weeks. The sections were stained with
antibodies against smooth muscle cells, endothelial cells, fibrinogen), von
Willebrand factor (vWF), platelets (CD31), macrophages (RAM-II or CD88)
and iNOS. After angiopleety RAM-II and iNOS reactive cells were present in
the adventitia and in intramural thrombi, but not in the media. The number of
iNOS reactive cells was proportional to the number of RAM-11 reactive cella.
Smooth muscle cells were not reactive for iNOS. In the thrombi the number
of iNOS and RAM-II reactive cells increased significantly the first 3 weeks,
whereas their number did not change in the adventitia.
1 week (n = 5) 2 weeks (n = 6) 3 weeks (n = 17)
Thrombus iNOS 0,6 + 0,6 1.7 + 0.5 2.6 + 0.2”
RAM-11 1.6 + 0,6 3,3 * 0,5 3.s * 0.1”
Advsntitia iNOS 1.6 + 0.5 2.0 * 0.4 1.0 * 0.2
RAM-11 3.0 * 0.3 2.9 * 0.3 2.6 h 0.2
Mean score + SEM, *p s 0.01 vs week 1.
In human coronary atherosclerotic plaques, obtained by athereotomy,
iNOS was present in macrophages of ruptured plaquea and the associated
thrombi, and in macrophages around the necrotic core.
Conclusion: In the rabbit angioplasty lesions, the iNOS immunoreacfivity
was present in macrophages, that were mainly found in colonizing intramural
thrombi and the adventitia. In non-ruptured human coronary plaques, iNOS
wee also found in macrophages around the necrotic core and the cslcifi-
cetions. The ruptured atherosclerotic plaques showed additionally a dense
infiltration of the fibrous cap by iNOS expressing macrophages.
